Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes

被引:315
作者
Dayan, N
Touitou, E [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Dept Pharmaceut, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Fac Med, David R Bloom Ctr Pharm, Jerusalem, Israel
关键词
trihexyphenidyl; ethosomes; liposomes; skin; permeation enhancement; transdermal delivery; Parkinson; surface activity;
D O I
10.1016/S0142-9612(00)00063-6
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The purpose of this work was to characterize a novel ethosomal carrier containing trihexyphenidyl HCl (THP) and to investigate the delivery of THP from ethosomes versus classic liposomes. THP-ethosomal systems were shown by electron microscopy to contain small, phospholipid vesicles. As the THP concentration was increased from 0 to 3%, the size of the vesicles decreased from 154 to 90 nm. This is most likely due to the surface activity of THP (critical micelle concentration of 5.9 mg/ml), as measured in this work. In addition, the ethosome zeta potential value increased as a function of THP concentration, from -4.5 to +10.4 when the THP concentration was increased from 0 to 3%. In contrast, THP liposomes were much larger and their charge was not affected by THP. When compared with standard liposomes, ethosomes had a higher entrapment capacity and a greater ability to deliver entrapped fluorescent probe to the deeper layers of skin. The flux of THP through nude mouse skin from THP ethosomes (0.21 mg/cm(2) h) was 87, 51 and 4.5 times higher than from liposomes, phosphate buffer and hydroethanolic solution, respectively (p < 0.01). The quantity of THP remaining in the skin at the end of the 18-h experiment was statistically significantly greater from the ethosomal system than from liposomes or a control hydroethanolic solution. Our results indicate that the ethosomal THP system may be a promising candidate for transdermal delivery of THP. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1879 / 1885
页数:7
相关论文
共 15 条
[1]   AGGREGATION OF ANTI-ACETYLCHOLINE DRUGS IN AQUEOUS-SOLUTION - MICELLAR PROPERTIES OF SOME DIPHENYLMETHANE DERIVATIVES [J].
ATTWOOD, D .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (05) :407-409
[2]   PHARMACOKINETICS OF TRIHEXYPHENIDYL AFTER SHORT-TERM AND LONG-TERM ADMINISTRATION TO DYSTONIC PATIENTS [J].
BURKE, RE ;
FAHN, S .
ANNALS OF NEUROLOGY, 1985, 18 (01) :35-40
[3]  
Elka Touitou, 1996, US patent, Patent No. [5540934A, 5540934, US5540934A]
[4]  
GILMAN AG, 1992, PHARMACOL BASIS THER, P160
[5]   The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: Entrapment efficiency and ultracentrifugation damage [J].
Heeremans, JLM ;
Gerritsen, HR ;
Meusen, SP ;
Mijnheer, RW ;
Panday, RSG ;
Prevost, R ;
Kluft, C ;
Crommelin, DJA .
JOURNAL OF DRUG TARGETING, 1995, 3 (04) :301-310
[6]  
HERNANDEZBORRELL J, 1990, J MICROENCAPSUL, V7, P255
[7]   Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids [J].
KaplunFrischoff, Y ;
Touitou, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (12) :1394-1399
[8]  
MCINNIS M, 1985, ACTA PSYCHIAT SCAND, V71, P297
[9]  
NEW RRC, 1990, LIPOSOMES PRACTICAL, P36
[10]  
PRADAS TNV, 1992, PHARMAZIE, V47, P231